Shulman Joseph — SEC Form 4 filings
SEC reporting owner CIK 1909855. 25 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-02-05 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 35 legs across 21 filings — 212,885 shares, $14,143,851 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: sale of 48,177 shares @ $50.14 ($2,415,503) in RHYTHM PHARMACEUTICALS, INC., filed 2024-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Technical Officer | 25 | — | 35 legs · 212,885 sh · $14,143,851 | 65 |
Form 4 filings — Shulman Joseph
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,024 @ $6.80 · Sale (S): 5,079 @ $119.75 · Option exercise (M): 2,024 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 16,968 · Tax withholding (F): 6,507 @ $108.99 · Option exercise (M): 2,656 (derivative) @ $0 · Option exercise (M): 3,937 (derivative) @ $0 · Option exercise (M): 4,125 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 9,748 @ $30.66 · Sale (S): 9,748 @ $115.24 · Option exercise (M): 9,748 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,094 @ $27.35 · Option exercise (M): 721 @ $30.66 · Sale (S): 2,815 @ $115.01 · Option exercise (M): 2,094 (derivative) @ $0 · Option exercise (M): 721 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,093 @ $27.35 · Option exercise (M): 12,344 @ $30.66 · Sale (S): 2,693 @ $110.95 · Sale (S): 8,332 @ $112.06 · Sale (S): 3,412 @ $112.81 · Option exercise (M): 2,093 (derivative) @ $0 · +1 more | EDGAR |
| 2025-09-04 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,094 @ $27.35 · Option exercise (M): 14,687 @ $30.66 · Sale (S): 16,781 @ $105.30 · Option exercise (M): 2,094 (derivative) @ $0 · Option exercise (M): 14,687 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,188 @ $27.35 · Sale (S): 4,188 @ $100.07 · Option exercise (M): 4,188 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,984 @ $6.80 · Sale (S): 3,984 @ $90.08 · Option exercise (M): 3,984 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 7,969 @ $6.80 · Sale (S): 3,984 @ $75.56 · Sale (S): 3,985 @ $80 · Option exercise (M): 7,969 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,125 · Sale (S): 1,228 @ $57.22 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Option exercise (M): 4,125 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 462 @ $56.39 · Sale (S): 7 @ $57.09 | EDGAR |
| 2025-02-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,656 · Option exercise (M): 1,562 · Sale (S): 791 @ $57.51 · Sale (S): 3 @ $57.54 · Option exercise (M): 2,656 (derivative) @ $0 · Option exercise (M): 1,562 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,938 · Sale (S): 1,281 @ $59.43 · Option exercise (M): 3,938 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 7,969 @ $6.80 · Option exercise (M): 5,312 @ $21.38 · Sale (S): 6,604 @ $65.73 · Sale (S): 5,977 @ $67.05 · Sale (S): 700 @ $67.83 · Option exercise (M): 7,969 (derivative) @ $0 · +1 more | EDGAR |
| 2024-11-13 | 4/A | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 65,175 @ $21.38 · Option exercise (M): 3,985 @ $6.80 · Option exercise (M): 65,175 (derivative) @ $0 · Option exercise (M): 3,985 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 10,468 @ $27.35 · Sale (S): 10,468 @ $53.00 · Option exercise (M): 10,468 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 5,313 @ $21.38 · Sale (S): 5,313 @ $50.01 · Option exercise (M): 5,313 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,984 @ $6.80 · Sale (S): 3,484 @ $38.38 · Sale (S): 500 @ $39.10 · Option exercise (M): 3,984 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 18,235 @ $40.34 | EDGAR |
| 2024-03-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 15,515 @ $39.22 | EDGAR |
| 2024-02-21 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 33,750 @ $0 · Grant/award (A): 16,500 (derivative) @ $0 · Grant/award (A): 50,250 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 1,865 @ $50 · Sale (S): 1,089 @ $50.01 | EDGAR |
| 2024-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,656 · Option exercise (M): 69,190 @ $21.38 · Sale (S): 100 @ $48.24 · Sale (S): 48,177 @ $50.14 · Sale (S): 23,397 @ $50.88 · Sale (S): 100 @ $51.52 · +6 more | EDGAR |
| 2024-02-05 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,938 · Sale (S): 1,324 @ $45.06 · Option exercise (M): 3,938 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909855 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →